Supplementary Table 1.
Clinical Characteristics and Fecal Examinations
COVID-19 Pneumonia |
COVID-19 |
Non–COVID-19 Pneumoniae |
Lung Tumora |
Healthy Subjectf,g |
P Valueh |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Survivor | Nonsurvivor | P Valuem | Nonsevere | Severeb | Criticalc | P valued | ||||||
Age | 56.5 ±15.2 | 72.8 ± 14.1 | <.001 | 52.9 ± 14.9 | 60.3 ± 14.6i | 71.4 ± 13.5j | <.001 | 57.8 ± 15.7 | 56.9 ± 15.7 | 56.9 ± 10.9 | 44.6 ± 12.1j | <.001 |
Sex | ||||||||||||
Male | 59 | 8 | .12 | 32 | 24 | 11 | .237 | 67 | 67i | 43 | 102 | .010 |
Female | 77 | 4 | 44 | 31 | 6 | 81 | 45 | 56 | 146 | |||
Discharge status | ||||||||||||
Survivor | 136 | - | NA | 76 | 55 | 5 | <.001 | 136 | - | - | - | NA |
Nonsurvivor | - | 12 | 0 | 0 | 12 | 12 | - | - | - | |||
Nausea | ||||||||||||
None | 133 | 12 | .999 | 75 | 53 | 17 | .704 | 145 | 110 | 99 | - | .456 |
Yes | 3 | 0 | 1 | 2 | 0 | 3 | 2 | 0 | - | |||
Emesis | ||||||||||||
None | 135 | 12 | .999 | 76 | 54 | 17 | .486 | 147 | 112 | 99 | - | .999 |
Yes | 1 | 0 | 0 | 1 | 0 | 1 | - | 0 | - | |||
Anorexia | ||||||||||||
None | 115 | 6 | .009 | 61 | 49 | 11 | .067 | 121 | 87 | 99j | - | <.001 |
Yes | 21 | 6 | 15 | 6 | 6 | 27 | 25 | 0 | - | |||
Jaundice | ||||||||||||
None | 135 | 12 | .999 | 75 | 55 | 17 | .999 | 147 | 112 | 99 | - | .999 |
Yes | 1 | 0 | 1 | 0 | 0 | 1 | - | 0 | - | |||
Abdominal pain | ||||||||||||
None | 135 | 11 | .156 | 76 | 54 | 16 | .098 | 146 | 112 | 99 | - | .341 |
Yes | 1 | 1 | 0 | 1 | 1 | 2 | - | 0 | - | |||
Abdominal distension | ||||||||||||
None | 136 | 11 | .081 | 76 | 55 | 16 | .115 | 147 | 111 | 99 | - | .999 |
Yes | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | - | |||
Diarrhea | ||||||||||||
None | 120 | 10 | .641 | 68 | 47 | 15 | .822 | 130 | 109i | 99j | - | <.001 |
Yes | 16 | 2 | 8 | 8 | 2 | 18 | 3 | 0 | - | |||
Gastrointestinal symptoms | ||||||||||||
None | 101 | 5 | .039 | 55 | 41 | 10 | .445 | 106 | 84 | 99j | - | <.001 |
Yes | 35 | 7 | 21 | 14 | 7 | 42 | 28 | 0 | - | |||
Stool color | ||||||||||||
Yellow | 133 | 7 | <.001 | 74 | 54 | 12j | .001 | 140 | 110 | 97 | 137 | .468 |
Brown | 3 | 2 | 2 | 1 | 2 | 5 | 2 | 2 | 1 | |||
Dark green | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | |||
Dark red | 0 | 2 | 0 | 0 | 2 | 2 | 0 | 0 | 0 | |||
Stool property | ||||||||||||
Soft | 124 | 5 | <.001 | 69 | 51 | 9j | .001 | 129 | 84j | 82j | 116j | <.001 |
Half loose | 0 | 0 | 0 | 0 | 0 | - | 20 | 13 | 21 | |||
Loose | 9 | 4 | 5 | 4 | 4 | 13 | 8 | 4 | 1 | |||
Watery | 0 | 2 | 0 | 0 | 2 | 2 | 0 | 0 | 0 | |||
Mushy | 2 | 1 | 2 | 0 | 1 | 3 | 0 | 0 | 0 | |||
Mucoid | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | |||
Leukocyte | ||||||||||||
None | 134 | 9 | .004 | 75 | 55 | 13j | .001 | 143 | 111 | 98 | 138 | .096 |
Yes | 2 | 3 | 1 | 0 | 4 | 5 | 1 | 1 | 0 | |||
Erythrocyte | ||||||||||||
None | 136 | 11 | .081 | 76 | 55 | 16 | .115 | 147 | 112 | 98 | 138 | .574 |
Yes | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | |||
Lipid droplet | ||||||||||||
None | 136 | 12 | NA | 76 | 55 | 17 | NA | 148 | 110 | 93i | 127j | <.001 |
Yes | - | - | - | - | - | 0 | 2 | 6 | 11 | |||
Yeast-like fungi | ||||||||||||
None | 136 | 12 | NA | 76 | 55 | 17 | NA | 148 | 105i | 98 | 137 | .001 |
Yes | - | - | - | - | - | 0 | 7 | 1 | 1 | |||
Stool OBk | ||||||||||||
None | 112 | 4 | <.001 | 61 | 48 | 7j | <.001 | 116 | 92l | 83 | 188 | .033 |
Weakly positive | 3 | 0 | 2 | 0 | 1 | 3 | 12 | 8 | 9 | |||
Positive | 1 | 5 | 0 | 1 | 5 | 6 | 7 | 8 | 13 | |||
Strongly positive | 0 | 3 | 0 | 0 | 3 | 3 | 0 | 0 | 0 |
COVID-19, coronavirus disease-2019.
Statistical comparison between COVID-19 group and lung tumor group.
Statistical comparison between the nonsevere and severe cases in COVID-19 group.
Statistical comparison between the critical subgroup and noncritical subgroup (mild and severe cases) in patients with COVID-19.
Statistical comparison among the mild, severe, and critical cases in COVID-19 group.
Statistical comparison between COVID-19 group and non–COVID-19 pneumonia group.
There were 248 healthy subjects who received 210 fecal OB tests and 138 stool tests.
Statistical comparison between COVID-19 group and healthy subjects.
Statistical comparison among COVID-19, non–COVID-19 pneumonia, lung tumor and healthy subjects.
P < .01.
P < .001.
Twenty patients with COVID-19 and 1 non–COVID-19 pneumonia patients did not have stool OB test.
P < .05.
Statistical comparison between survivor group and nonsurvivor group.